Newron Pharmaceuticals Spa (0QOI)
LSE
Year End December 30 2023 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|
EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
Total Assets | 56.59M | 73.02M | 59.73M | 60.29M | 51.2M | 50.49M | 37.2M | 25.87M |
Total Current Assets | 56.14M | 72.8M | 59.51M | 59.95M | 37.87M | 39.43M | 28.49M | 19.65M |
Cash and Equivalents | 42.95M | 56.29M | 27.62M | 20.27M | 13.21M | 25.02M | 13.42M | 6.34M |
Total Non-Current Assets | 49.75M | 67.72M | 54.84M | 36.8M | 17.25M | 3.11M | -14.03M | -29.91M |
Total Liabilities | 6.84M | 5.3M | 4.89M | 23.49M | 33.95M | 47.38M | 51.23M | 55.77M |
Total Current Liabilities | 6.65M | 4.73M | 4.28M | 5.6M | 6.89M | 3.65M | 5.04M | 28.93M |
Total Non-Current Liabilities | 199k | 576k | 606k | 34.64M | 52.73M | 86.27M | 91.35M | 52.6M |
Total Equity | 49.75M | 67.72M | 54.84M | 36.8M | 17.25M | 3.11M | -14.03M | -29.91M |
Common Equity | 3.16M | 3.57M | 3.57M | 3.57M | 3.57M | 3.57M | 3.57M | 3.57M |
Retained Earnings | -19.78M | -10.46M | -20.2M | -25.34M | -26.16M | -20.12M | -22.81M | -21.4M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.